About Inotiv, Inc.
https://www.inotivco.comInotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products.
CEO
Robert W. Leasure Jr.
Compensation Summary
(Year 2012)
ETFs Holding This Stock
Summary
Showing Top 3 of 14
Ratings Snapshot
Rating : C
Most Recent Analyst Grades
Grade Summary
Showing Top 1 of 1
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:1.4M
Value:$854.08K
BALYASNY ASSET MANAGEMENT L.P.
Shares:985.74K
Value:$599.33K
RENAISSANCE TECHNOLOGIES LLC
Shares:359.76K
Value:$218.74K
Summary
Showing Top 3 of 80
About Inotiv, Inc.
https://www.inotivco.comInotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $138.14M ▲ | $25.87M ▼ | $-8.55M ▲ | -6.19% ▲ | $-0.25 ▲ | $13.94M ▲ |
| Q3-2025 | $130.68M ▲ | $39.6M ▲ | $-17.58M ▼ | -13.45% ▼ | $-0.51 ▼ | $9.56M ▼ |
| Q2-2025 | $124.32M ▲ | $31.93M ▼ | $-14.87M ▲ | -11.96% ▲ | $-0.44 ▲ | $11.29M ▲ |
| Q1-2025 | $119.88M ▼ | $40.55M ▼ | $-27.63M ▼ | -23.05% ▼ | $-1.02 ▼ | $-1.79M ▼ |
| Q4-2024 | $130.42M | $43.11M | $-18.89M | -14.49% | $-0.73 | $2.87M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $21.74M ▲ | $771.11M ▲ | $635.09M ▲ | $136.03M ▼ |
| Q3-2025 | $6.21M ▼ | $759.74M ▼ | $615.95M ▲ | $143.78M ▼ |
| Q2-2025 | $19.3M ▼ | $765.97M ▼ | $608.27M ▲ | $157.69M ▼ |
| Q1-2025 | $38.04M ▲ | $772.91M ▼ | $603.08M ▼ | $169.83M ▼ |
| Q4-2024 | $21.43M | $781.36M | $610.86M | $170.5M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $-8.55M ▲ | $14.3M ▲ | $-475K ▲ | $1.62M ▲ | $15.53M ▲ | $11.63M ▲ |
| Q3-2025 | $-17.58M ▼ | $-7.45M ▲ | $-2.51M ▲ | $-3.41M ▼ | $-13.08M ▲ | $-11.45M ▲ |
| Q2-2025 | $-14.87M ▲ | $-12.81M ▼ | $-5.45M ▼ | $-632K ▼ | $-18.74M ▼ | $-18.29M ▼ |
| Q1-2025 | $-27.63M ▼ | $-4.5M ▼ | $-4.46M ▲ | $26.13M ▲ | $16.61M ▲ | $-8.96M ▼ |
| Q4-2024 | $-18.89M | $-2.37M | $-5.25M | $14.56M | $7M | $-7.67M |
Revenue by Products
| Product | Q4-2024 | Q2-2025 | Q3-2025 | Q4-2025 |
|---|---|---|---|---|
 Product | $130.00M ▲ | $70.00M ▼ | $70.00M ▲ | $140.00M ▲ |
 Service | $110.00M ▲ | $60.00M ▼ | $60.00M ▲ | $120.00M ▲ |
Revenue by Geography
| Region | Q4-2024 | Q4-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
 NETHERLANDS | $20.00M ▲ | $20.00M ▲ | $0 ▼ | $10.00M ▲ |
 UNITED STATES | $200.00M ▲ | $220.00M ▲ | $110.00M ▼ | $120.00M ▲ |
CEO
Robert W. Leasure Jr.
Compensation Summary
(Year 2012)
ETFs Holding This Stock
Summary
Showing Top 3 of 14
Ratings Snapshot
Rating : C
Most Recent Analyst Grades
Grade Summary
Showing Top 1 of 1
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:1.4M
Value:$854.08K
BALYASNY ASSET MANAGEMENT L.P.
Shares:985.74K
Value:$599.33K
RENAISSANCE TECHNOLOGIES LLC
Shares:359.76K
Value:$218.74K
Summary
Showing Top 3 of 80